Champions Oncology, Inc. - Common Stock (NQ:CSBR)
5.900
+0.050
(+0.85%)
Streaming Delayed Price
Updated: 11:52 AM EST, Feb 18, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Insights Ahead: Champions Oncology's Quarterly Earnings ↗
September 12, 2025
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 15, 2025
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
September 15, 2025
Earnings Scheduled For September 15, 2025 ↗
September 15, 2025
Earnings Scheduled For July 23, 2025 ↗
July 23, 2025
Champions Oncology Announces Appointment of New CEO
July 18, 2025
Earnings Scheduled For March 11, 2025 ↗
March 11, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
January 17, 2025
Frequently Asked QuestionsIs Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 5.900
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 02/18/26 11:52 AM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 79.15M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 79M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
